Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8971 |
High Similarity |
NPD1510 |
Phase 2 |
0.8955 |
High Similarity |
NPD1240 |
Approved |
0.8936 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD4380 |
Phase 2 |
0.8841 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8841 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8824 |
High Similarity |
NPD1607 |
Approved |
0.8777 |
High Similarity |
NPD1549 |
Phase 2 |
0.8707 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8551 |
High Similarity |
NPD6651 |
Approved |
0.8542 |
High Similarity |
NPD2533 |
Approved |
0.8542 |
High Similarity |
NPD2534 |
Approved |
0.8542 |
High Similarity |
NPD2532 |
Approved |
0.8523 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8511 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.85 |
High Similarity |
NPD2796 |
Approved |
0.8451 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8414 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8411 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8389 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8333 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8289 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8267 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8264 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8239 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8219 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8212 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8165 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8108 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8095 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8092 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8089 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8089 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8069 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8054 |
Intermediate Similarity |
NPD920 |
Approved |
0.7987 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7987 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7986 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7975 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7962 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7945 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7945 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7925 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7895 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7888 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7875 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7872 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7834 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7832 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7826 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7806 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7791 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD7472 |
Approved |
0.777 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7762 |
Intermediate Similarity |
NPD943 |
Approved |
0.7756 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7736 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7736 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7733 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7716 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7704 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7697 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7687 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7683 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7681 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7671 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7636 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7607 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7595 |
Intermediate Similarity |
NPD3749 |
Approved |
0.758 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7568 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7566 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7562 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7551 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD919 |
Approved |
0.753 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7518 |
Intermediate Similarity |
NPD1203 |
Approved |
0.75 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6100 |
Approved |
0.75 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7482 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7466 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7466 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7465 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7455 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7432 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7417 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7368 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7361 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7357 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7343 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7333 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7319 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7305 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7292 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7285 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7283 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7261 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD411 |
Approved |
0.7257 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7257 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7244 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7233 |
Intermediate Similarity |
NPD37 |
Approved |
0.7222 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7216 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7154 |
Intermediate Similarity |
NPD940 |
Approved |
0.7154 |
Intermediate Similarity |
NPD846 |
Approved |
0.7153 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7152 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7143 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7099 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD4626 |
Approved |
0.709 |
Intermediate Similarity |
NPD9266 |
Approved |
0.709 |
Intermediate Similarity |
NPD74 |
Approved |
0.7078 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7049 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7039 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7039 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7039 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7034 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7021 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7015 |
Intermediate Similarity |
NPD9267 |
Approved |
0.7015 |
Intermediate Similarity |
NPD9263 |
Approved |
0.7015 |
Intermediate Similarity |
NPD9264 |
Approved |
0.7015 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7014 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7012 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7 |
Intermediate Similarity |
NPD6781 |
Approved |
0.6993 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6977 |
Remote Similarity |
NPD8313 |
Approved |
0.6977 |
Remote Similarity |
NPD8312 |
Approved |
0.6975 |
Remote Similarity |
NPD5760 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD5761 |
Phase 2 |
0.6974 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6973 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6972 |
Remote Similarity |
NPD1778 |
Approved |
0.6971 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD1876 |
Approved |
0.6966 |
Remote Similarity |
NPD1283 |
Approved |
0.6959 |
Remote Similarity |
NPD4625 |
Phase 3 |
0.6943 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6933 |
Remote Similarity |
NPD5353 |
Approved |
0.6929
|
Remote Similarity |
NPD405 |
Clinical (unspecified phase) |